TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Ekman Biomedical Data AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,008
|
384
|
91 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-298
|
142
|
-1 |
| EBITDA |
-320
|
124
|
-2 |
| Total assets |
1,123
|
1,245
|
1,037 |
| Current assets |
1,123
|
1,245
|
1,037 |
| Current liabilities |
291
|
115
|
19 |
| Equity capital |
832
|
1,130
|
1,018 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
1
|
0
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
74.1%
|
90.8%
|
98.2% |
| Turnover per employee | 1,008 | 91 | |
| Profit as a percentage of turnover |
-29.6%
|
37.0%
|
-1.1% |
| Return on assets (ROA) |
-26.5%
|
11.4%
|
-0.1% |
| Current ratio |
385.9%
|
1082.6%
|
5457.9% |
| Return on equity (ROE) |
-35.8%
|
12.6%
|
-0.1% |
| Change turnover |
624
|
293
|
54 |
| Change turnover % |
163%
|
322%
|
146% |
| Chg. No. of employees |
1
|
-1
|
0 |
| Chg. No. of employees % |
-100%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.